J. Joseph Kim
2019
In 2019, J. Joseph Kim earned a total compensation of $2.6M as President and Chief Executive Officer at Inovio Pharmaceuticals, a 16% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $457,222 |
---|---|
Option Awards | $642,803 |
Salary | $837,735 |
Stock Awards | $638,274 |
Other | $12,500 |
Total | $2,588,534 |
Kim received $837.7K in salary, accounting for 32% of the total pay in 2019.
Kim also received $457.2K in non-equity incentive plan, $642.8K in option awards, $638.3K in stock awards and $12.5K in other compensation.
Rankings
In 2019, J. Joseph Kim's compensation ranked 4,715th out of 13,971 executives tracked by ExecPay. In other words, Kim earned more than 66.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,715 out of 13,971 | 66th |
Division Manufacturing | 1,757 out of 5,701 | 69th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 242 out of 832 | 71st |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 139 out of 535 | 74th |
Industry Surgical and Medical Instruments and Apparatus | 86 out of 350 | 75th |
Source: SEC filing on March 25, 2021.
Kim's colleagues
We found three more compensation records of executives who worked with J. Joseph Kim at Inovio Pharmaceuticals in 2019.
News
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019